Recent successes in therapeutics for Ebola virus disease: no time for complacency

Item Type:

Publication

Title

Recent successes in therapeutics for Ebola virus disease: no time for complacency

Subject

Description

The PALM trial in the Democratic Republic of the Congo identified a statistically significant survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute Ebola virus disease; however, substantial gaps remain in improving the outcomes of acute Ebola virus disease and for the survivors.

Date Last Updated (Year-Month-Day)

2020-06-18

Citation

Iversen, Patrick L., Christopher D. Kane, Xiankun Zeng, Rekha G. Panchal, Travis K. Warren, Sheli R. Radoshitzky, Jens H. Kuhn, Rajini R. Mudhasani, Christopher L. Cooper, Amy C. Shurtleff, Farooq Nasar, Melek M. E. Sunay, Allen J. Duplantier, Brett P. Eaton, Elizabeth E. Zumbrun, Sandra L. Bixler, Shannon Martin, J. Matthew Meinig, Chih-Yuan Chiang, Mariano Sanchez-Lockhart, Gustavo F. Palacios, Jeffrey R. Kugelman, Karen A. Martins, Margaret L. Pitt, Ian Crozier, and David L. Saunders. 2020. "Recent successes in therapeutics for Ebola virus disease: no time for complacency." The Lancet Infectious Diseases.

Accessibility

Free online on Lancet site.

Share this page: